Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab
Journal of Clinical Medicine · 15.08.2026 · 15 (16) · 6319
DOI: 10.3390/jcm15166319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.08.2026. Verfasst von Paul Widmann-Sedlnitzky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Medical University of Vienna, 1090 Vienna, Austria. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Diabetic macular edema is caused by disruptions in the blood–retinal barrier, resulting in leakage and inflammation, appearing in optical coherence tomography as retinal fluid, hard exudates, and hyper-reflective foci. This study aimed to assess volumetric changes in hyper-reflective foci and hard exudates in faricimab-treated diabetic macular edema in real-world practice.
Methods
This retrospective longitudinal study included forty-four eyes with faricimab-treated diabetic macular edema and follow-up of ≥40 weeks. Optical coherence tomography scans were analyzed at baseline, post-loading, 6 months and 1 year. Hyper-reflective foci and hard exudates were quantified across macular subfields using a machine-learning algorithm with manual correction. Outcomes included volumetric changes, best-corrected visual acuity, and central subfield thickness. Early morphologic responders were defined post-loading by ≥20% central subfield thickness reduction and/or central subfield thickness below 280 µm.
Results
At 1 year, hyper-reflective foci and hard exudate volumes significantly decreased in the central subfield (median differences: −0.025 nL, p = 0.00028; −0.119 nL, p = 0.00025) and outer ring (−0.178 nL, p = 0.00041; −0.612 nL, p = 0.014). Hard exudate volume significantly decreased in the inner ring (−0.740 nL, p < 0.0001). Best-corrected visual acuity and central subfield thickness improved significantly (−0.10 logarithm of the minimum angle of resolution (logMAR), p = 0.0018; −48 µm, p < 0.0001). Total hyper-reflective foci volumes were similar between responders and non-responders. In contrast, hard exudate burden remained numerically higher in non-responders.
Conclusions
During the year following the switch to faricimab, HRF and HE burden decreased alongside visual and anatomical improvement. HRF volumes were descriptively similar between early CST responders and non-responders, whereas HE burden remained numerically higher in non-responders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Medical University of Vienna, 1090 Vienna, Austria.
- Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, 1090 Vienna, Austria.
- Carl Zeiss Meditec AG, 73447 Oberkochen, Germany.
- Department of Oncology, Center for Cancer Research, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Paul Widmann-Sedlnitzky, Heiko Stino, Ursula Schmidt-Erfurth, Stefan Sacu, Andreas Pollreisz
Zitieren
APA
Widmann-Sedlnitzky, P., Huber, K. L., Steiner, I., Gumpinger, M., Stino, H., Schmoll, T., Schmidt-Erfurth, U., Sacu, S., & Pollreisz, A. (2026). Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab. Journal of Clinical Medicine, 15(16), 6319. https://doi.org/10.3390/jcm15166319
Vancouver
Widmann-Sedlnitzky P, Huber KL, Steiner I, Gumpinger M, Stino H, Schmoll T, et al. Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab. Journal of Clinical Medicine. 2026;15(16):6319. doi:10.3390/jcm15166319
BibTeX
@article{WidmannSedlnitzky2026,
author = {Widmann-Sedlnitzky, Paul and Huber, Kim Lien and Steiner, Irene and Gumpinger, Markus and Stino, Heiko and Schmoll, Tilman and Schmidt-Erfurth, Ursula and Sacu, Stefan and Pollreisz, Andreas},
title = {Dynamics of Hyper-Reflective Foci and Hard Exudates in Diabetic Macular Edema Treated with Faricimab},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6319},
doi = {10.3390/jcm15166319}
}
EUVIMED